EVIO, Inc. (EVIO) ist ein börsennotiertes Unternehmen im Gesundheitswesen Sektor, tätig in der Drug Manufacturers - Specialty & Generic Branche. Der Hauptsitz des Unternehmens ist in Henderson, NV, United States. Der aktuelle CEO ist Lori Jean Glauser.
EVIO hat IPO-Datum 2004-01-21, 18 Vollzeitbeschäftigte, gelistet an der Other OTC, eine Marktkapitalisierung von $1.92M.
EVIO, Inc., together with its subsidiaries, provides analytical testing and advisory services to cannabis industry in the United States. The company's consulting services include advisory, product formulation, and licensing and compliance services. It also offers various testing services comprise cannabinoid potency testing, terpene analysis, pesticide testing, residual solvent screening, visual inspections, biological contaminant testing, and other services. EVIO, Inc. is headquartered in Henderson, Nevada.
